Evidence for symptom management in the child with cancer

Journal of Pediatric Hematology/Oncology

Volumn 28, Issue 9, 2006, Pages 601-615

  Ladas, Elena J ^a   Post White, Janice ^b   Hawks, Ria ^a   Taromina, Kathy ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cancer; Child; Symptom management

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ANTHRACYCLINE; ANTIEMETIC AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CARNITINE; CASCARA SAGRADA; CHAMOMILE; ESSENTIAL FATTY ACID; GINGER EXTRACT; GLUTAMINE; HERBACEOUS AGENT; HOMEOPATHIC AGENT; HYPERICUM PERFORATUM EXTRACT; IMMUNOCAL; ISPAGULA; KAVA; LAXATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; OLEA EUROPEA EXTRACT; PACLITAXEL; PEPPERMINT; PEPPERMINT OIL; PLANT EXTRACT; PROBIOTIC AGENT; PROTEIN; SENNA EXTRACT; TRAUMEEL S; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACUPUNCTURE; ALTERNATIVE MEDICINE; BREAST CANCER; CACHEXIA; CANCER; CANCER PAIN; CANCER RISK; CLINICAL TRIAL; CONSTIPATION; DECISION MAKING; DIARRHEA; DRUG EFFICACY; FAMILY; GINGER; HERB; HUMAN; HYPNOSIS; IMAGERY; LIVER TOXICITY; MEDICAL RESEARCH; MENTHA SPICATA; MUCOSA INFLAMMATION; NAUSEA; NEUROPATHY; OLEA EUROPEA; PAIN; PALLIATIVE THERAPY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; VOMITING;

ANXIETY; CACHEXIA; CHILD; CLINICAL TRIALS; COMPLEMENTARY THERAPIES; CONSTIPATION; HUMANS; MUCOSITIS; NAUSEA; NEOPLASMS; PAIN; QUALITY OF LIFE; VOMITING;

EID: 33749359701     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/01.mph.0000212989.26317.52     Document Type: Review

References (216)

1. Sencer S, Kelly KM. Bringing evidence to complementary and alternative medicine for children with cancer. J Pediatr Hematol Oncol. 2006;28:186-189.
2. Kelly KM, Jacobson JS, Kennedy DD, et al. Use of unconventional therapies by children with cancer at an urban medical center. J Pediatr Hematol Oncol. 2000;22:412-416.
3. Oeffinger KC, Hudson MM. Long-term complications following childhood and adolescent cancer: foundations for providing risk-based health care for survivors. CA Cancer J Clin. 2004;54:208-236.
4. Kelly KM. Complementary and alternative medical therapies for children with cancer. Eur J Cancer. 2004;40:2041-2046.
5. Ernst E. Heavy metals in traditional Indian remedies. Eur J Clin Pharmacol. 2002;57:891-896.
6. Ernst E. Toxic heavy metals and undeclared drugs in Asian herbal medicines. Trends Pharmacol Sci. 2002;23:136-139.
7. Center for Disease Control and Prevention (CDC). Lead poisoning associated with ayurvedic medications - five states, 2000-2003. MMWR Morb Mortal Wkly Rep. 2004;53:582-584.
8. Saper RB, Kales SN, Paquin J, et al. Heavy metal content of ayurvedic herbal medicine products. JAMA. 2004;292:2868-2873.
9. NYC Health Department warns against the use of herbal medicine products made in India that contain lead or mercury. December 21, 2005.
10. Ko RJ. A U.S. perspective on the adverse reactions from traditional Chinese medicines. J Chin Med Assoc. 2004;67:109-116.
11. Post-White J, Sencer S, Fitzgerald M. Complementary and alternative treatments in children with cancer. In: Kelly K, Baggott C, Foley G, eds. Nursing Care of the Child with Cancer. 2nd ed. Philadelphia: WB Saunders; 2002:256-263.
12. Ladas E, Post-White J. Complementary and Alternative Medicine in Pediatric Oncology. In: Carroll B, Finlay J, eds. Cancer in Children. Edited chapter in submission, 2006.
13. Smith WB. Research methodology: implications for CAM pain research. Clin J Pain. 2004;20:3-7.
14. Block KI, Burns B, Cohen AJ, et al. Point-counterpoint: using clinical trials for the evaluation of integrative cancer therapies. Integr Cancer Ther. 2004;3:66-81.
15. Carter B. Methodological issues and complementary therapies: researching intangibles? Complement Ther Nurs Midwifery. 2003;9:133-139.
16. Committee on the Use of Complementary and Alternative Medicine by the American Public, Board on Health Promotion and Disease Prevention. Complementary and Alternative Medicine in the United States. Washington, DC: The National Academies Press; 2005:144-149.
17. Sampson M, Campbell K, Ajiferuke I, et al. Randomized controlled trials in pediatric complementary and alternative medicine: where can they be found? BMC Pediatr. 2003;3:1.
18. Steves R, Hootman JM. Evidence-based medicine: what is it and how does it apply to athletic training? J Athl Train. 2004;39:83-87.
19. Weiger WA, Smith M, Boon H, et al. Advising patients who seek complementary and alternative medical therapies for cancer. Ann Intern Med. 2002;137:889-903.
20. Ladas EJ, Sacks N, Meacham LR, et al. A review of the nutritional practices for the pediatric oncology population; assessment, intervention, nursing, pharmacology, quality of life, and survivorship. Nutr Clin Practice. 2005;20:377-393.
21. Meacham LR, Mazewski C, Krawiecki N. Mechanism of transient adrenal insufficiency with megestrol acetate treatment of cachexia in children with cancer. J Pediatr Hematol Oncol. 2003;25:414-417.
22. Argiles JM, Lopez-Soriano FJ. The role of cytokines in cancer cachexia. Med Res Rev. 1999;19:223-248.
23. Argiles JM, Moore-Carrasco R, Fuster G, et al. Cancer cachexia: the molecular mechanisms. Int J Biochem Cell Biol. 2003;35:405-409.
24. van Eys J. Nutrition and cancer: physiological interrelationships. Annu Rev Nutr. 1985;5:435-461.
25. Saarinen UM, Koskelo EK, Teppo AM, et al. Tumor necrosis factor in children with malignancies. Cancer Res. 1990;50:592-595.
26. Pratt VC, Watanabe S, Bruera E, et al. Plasma and neutrophil fatty acid composition in advanced cancer patients and response to fish oil supplementation. Br J Cancer. 2002;87:1370-1378.
27. Brown TT, Zelnik DL, Dobs AS. Fish oil supplementation in the treatment of cachexia in pancreatic cancer patients. Int J Gastrointest Cancer. 2003;34:143-150.
28. Falconer JS, Fearon KC, Ross JA, et al. Polyunsaturated fatty acids in the treatment of weight-losing patients with pancreatic cancer. World Rev Nutr Diet. 1994;76:74-76.
29. Burns CP, Halabi S, Clamon GH, et al. Phase I clinical study of fish oil fatty acid capsules for patients with cancer cachexia: cancer and leukemia group B study 9473. Clin Cancer Res. 1999;5:3942-3947.
30. Wigmore SJ, Ross JA, Falconer JS, et al. The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition. 1996;12:S27-S30.
31. Barber MD, Fearon KC, Tisdale MJ, et al. Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia. Nutr Cancer. 2001;40:118-124.
32. Barber MD, McMillan DC, Preston T, et al. Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement. Clin Sci (London). 2000;98:389-399.
33. Barber MD, Ross JA, Preston T, et al. Fish oil-enriched nutritional supplement attenuates progression of the acute-phase response in weight-losing patients with advanced pancreatic cancer. J Nutr. 1999;129:1120-1125.
34. Wigmore SJ, Barber MD, Ross JA, et al. Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer. Nutr Cancer. 2000;36:177-184.
35. Bruera E, Strasser F, Palmer JL, et al. Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study. J Clin Oncol. 2003;21:129-134.
36. Gogos CA, Ginopoulos P, Salsa B, et al. Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: a randomized control trial. Cancer. 1998;82:395-402.
37. Fearon KC, Von Meyenfeldt MF, Moses AG, et al. Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut. 2003;52:1479-1486.
38. Gianotti L, Braga M, Fortis C, et al. A prospective, randomized clinical trial on perioperative feeding with an arginine-, omega-3 fatty acid-, and RNA-enriched enteral diet: effect on host response and nutritional status. J Parenter Enteral Nutr. 1999;23:314-320.
39. Grey V, Mohammed SR, Smountas AA, et al. Improved glutathione status in young adult patients with cystic fibrosis supplemented with whey protein. J Cyst Fibros. 2003;2:195-198.
40. Micke P, Beeh KM, Buhl R. Effects of long-term supplementation with whey proteins on plasma glutathione levels of HIV-infected patients. Eur J Nutr. 2002;41:12-18.
41. Micke P, Beeh KM, Schlaak JF, et al. Oral supplementation with whey proteins increases plasma glutathione levels of HIV-infected patients. Eur J Clin Invest. 2001;31:171-178.
42. Melnick SJ, Rogers P, Sacks N, et al. A pilot limited institutional study to evaluate the safety and tolerability of Immunocal®, a nutraceutical cysteine delivery agent in the management of wasting in high-risk childhood cancer patients. First Annual Chicago Supportive Oncology Conference, 2005.
43. Kemper KJ, Sarah R, Silver-Highfield E, et al. On pins and needles? Pediatric pain patients' experience with acupuncture. Pediatrics. 2000;105:941-947.
44. Reindl TK, Geilen W, Hartmann R, et al. Acupuncture against chemotherapy-induced nausea and vomiting in pediatric oncology Interim results of a multicenter crossover study. Support Care Cancer. 2006;14:172-176.
45. Ezzo J, Vickers A, Richardson MA, et al. Acupuncture-point stimulation for chemotherapy-induced nausea and vomiting. J Clin Oncol. 2005;23:7188-7198.
46. Vickers AJ, Straus DJ, Fearon B, et al. Acupuncture for postchemotherapy fatigue: a phase II study. J Clin Oncol. 2004;22:1731-1735.
47. NIH Consensus Conference. Acupuncture. JAMA. 1998;280:1518-1524.
48. CANCER. GOV-Clinical Trials [database online]. Bethesda, MD: National Cancer Institute; 2006. Updated March 8, 2006.
49. Roscoe JA, Morrow GR, Hickok JT, et al. The efficacy of acupressure and acustimulation wrist bands for the relief of chemotherapy-induced nausea and vomiting. A University of Rochester Cancer Center Community Clinical Oncology Program multicenter study. J Pain Symptom Manage. 2003;26:731-742.
50. Treish I, Shord S, Valgus J, et al. Randomized double-blind study of the Reliefband as an adjunct to standard antiemetics in patients receiving moderately-high to highly emetogenic chemotherapy. Support Care Cancer. 2003;11:516-521.
51. Lien HC, Sun WM, Chen YH, et al. Effects of ginger on motion sickness and gastric slow-wave dysrhythmias induced by circular vection. Am J Physiol Gastrointest Liver Physiol. 2003;284:G481-G489.
52. Fischer-Rasmussen W, Kjaer SK, Dahl C, et al. Ginger treatment of hyperemesis gravidarum. Eur J Obstet Gynecol Reprod Biol. 1991;38:19-24.
53. Sripramote M, Lekhyananda N. A randomized comparison of ginger and vitamin B6 in the treatment of nausea and vomiting of pregnancy. J Med Assoc Thai. 2003;86:846-853.
54. Vutyavanich T, Kraisarin T, Ruangsri R. Ginger for nausea and vomiting in pregnancy: randomized, double-masked, place-bocontrolled trial. Obstet Gynecol. 2001;97:577-582.
55. Willetts KE, Ekangaki A, Eden JA. Effect of a ginger extract on pregnancy-induced nausea: a randomised controlled trial. Aust N Z J Obstet Gynaecol. 2003;43:139-144.
56. Pongrojpaw D, Chiamchanya C. The efficacy of ginger in prevention of post-operative nausea and vomiting after outpatient gynecological laparoscopy. J Med Assoc Thai. 2003;86:244-250.
57. Betz O, Kranke P, Geldner G, et al. Is ginger a clinically relevant antiemetic? A systematic review of randomized controlled trials. Forsch Komplementarmed Klass Naturheilkd. 2005;12:14-23.
58. Tate S. Peppermint oil: a treatment for postoperative nausea. J Adv Nurs. 1997;26:543-549.
59. Buckle J. Nausea and Vomitting. Clinical Aromatherapy: Essential Oils in Practice. 2nd ed. Arnold, UK: Churchill Livingstone; 2003.
60. Asao T, Mochiki E, Suzuki H, et al. An easy method for the intraluminal administration of peppermint oil before colonoscopy and its effectiveness in reducing colonic spasm. Gastrointest Endosc. 2001;53:172-177.
61. Leicester RJ, Hunt RH. Peppermint oil to reduce colonic spasm during endoscopy. Lancet. 1982;2:989.
62. McKenzie J, Gallacher M. A sweet smelling success. Nurs Times. 1989;85:48-49.
63. Anderson LA, Gross JB. Aromatherapy with peppermint, isopropyl alcohol, or placebo is equally effective in relieving postoperative nausea. J Perianesth Nurs. 2004;19:29-35.
64. Cooke B, Ernst E. Aromatherapy: a systematic review. Br J Gen Pract. 2000;50:493-496.
65. Zeltzer LK, Dolgin MJ, LeBaron S, et al. A randomized, controlled study of behavioral intervention for chemotherapy distress in children with cancer. Pediatrics. 1991;88:34-42.
66. Ramkumar D, Rao SS. Efficacy and safety of traditional medical therapies for chronic constipation: systematic review. Am J Gastroenterol. 2005;100:936-971.
67. Fleming T, Gruenwald J, Brendler T, et al. eds. PDR for Herbal Medicine. 2nd ed. Montvale, NJ: Medical Economics Company; 2000:516-520.
68. Natural Medicine Comprehensive Database [database online]. Stockton, CA: Natural Medicine Comprehensive Database; 1995. Updated: February 27, 2006.
69. Palsson OS, Heymen S, Whitehead WE. Biofeedback treatment for functional anorectal disorders: a comprehensive efficacy review. Appl Psychophysiol Biofeedback. 2004;29:153-174.
70. Kelly GS. Bovine colostrums: a review of clinical uses. Altern Med Rev. 2003;8:378-394.
71. Inoue M, Okamura T, Sawada A, et al. Colostrum and severe gut GVHD. Bone Marrow Transplant. 1998;22:402-403.
72. Mitra AK, Mahalanabis D, Ashraf H, et al. Hyperimmune cow colostrum reduces diarrhoea due to rotavirus: a double-blind, controlled clinical trial. Acta Paediatr. 1995;84:996-1001.
73. Sarker SA, Casswall TH, Mahalanabis D, et al. Successful treatment of rotavirus diarrhea in children with immunoglobulin from immunized bovine colostrum. Pediatr Infect Dis J. 1998;17:1149-1154.
74. Tawfeek HI, Najim NH, Al Mashikhi S. Efficacy of an infant formula containing anti-Escherichia coli colostral antibodies from hyperimmunized cows in preventing diarrhea in infants and children: a field trial. Int J Infect Dis. 2003;7:120-128.
75. Szajewska H, Mrukowicz JZ. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials. J Pediatr Gastroenterol Nutr. 2001;33 (suppl 2):S17-S25.
76. Bin-Nun A, Bromiker R, Wilschanski M, et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr. 2005;147:192-196.
77. Euler AR, Mitchell DK, Kline R, et al. Prebiotic effect of fructo-oligosaccharide supplemented term infant formula at two concentrations compared with unsupplemented formula and human milk. J Pediatr Gastroenterol Nutr. 2005;40:157-164.
78. Salminen MK, Tynkkynen S, Rautelin H, et al. The efficacy and safety of probiotic Lactobacillus rhamnosus GG on prolonged, noninfectious diarrhea in HIV Patients on antiretroviral therapy: a randomized, placebo-controlled, crossover study. HIV Clin Trials. 2004;5:183-191.
79. Anderson PM, Ramsay NK, Shu XO, et al. Effect of low-dose oral glutamine on painful stomatitis during bone marrow transplantation. Bone Marrow Transplant. 1998;22:339-344.
80. Anderson PM, Schroeder G, Skubitz KM. Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy. Cancer. 1998;83:1433-1439.
81. Vahdat L, Papadopoulos K, Lange D, et al. Reduction of paclitaxel-induced peripheral neuropathy with glutamine. Clin Cancer Res. 2001;7:1192-1197.
82. Ladas EJ, Sands S, Kelly KM, et al. A pilot study investigating the effects of glutamine and vincristine-induced neuropathy in pediatric patients with cancer. 2006. Available at www.integrativetherapiesprogram. org/research/studies.
83. Argyriou AA, Chroni E, Koutras A, et al. Vitamin E for prophylaxis against chemotherapy-induced neuropathy: a randomized controlled trial. Neurology. 2005;64:26-31.
84. Oberbaum M, Yaniv I, Ben GY, et al. A randomized, controlled clinical trial of the homeopathic medication TRAUMEEL S in the treatment of chemotherapy-induced stomatitis in children undergoing stem cell transplantation. Cancer. 2001;92:684-690.
85. Escalante CP, Grover T, Johnson BA, et al. A fatigue clinic in a comprehensive cancer center: design and experiences. Cancer. 2001;92:1708-1713.
86. Ahles TA, Tope DM, Pinkson B, et al. Massage therapy for patients undergoing autologous bone marrow transplantation. J Pain Symptom Manage. 1999;18:157-163.
87. Post-White J, Kinney ME, Savik K, et al. Therapeutic massage and healing touch improve symptoms in cancer. Integr Cancer Ther. 2003;2:332-344.
88. Post-White J. Complementary and alternative medicine in pediatric oncology. J Pediatr Oncol Nursing. 2006;23:244-253.
89. Iwasaki M. Interventional study on fatigue relief in mothers caring for hospitalized children-effect of massage incorporating techniques from oriental medicine. Kurume Med J. 2005;52:19-27.
90. Cruciani RA, Dvorkin E, Homel P, et al. L-carnitine supplementation for the treatment of fatigue and depressed mood in cancer patients with carnitine deficiency: a preliminary analysis. Ann N Y Acad Sci. 2004;1033:168-176.
91. Esteban-Cruciani NV. Severe carnitine deficiency in children with AIDS: improved functional activity status after supplementation [abstracts]. Pediatr Res. 2001;49:254.
92. Esteban-Cruciani NV. High prevalence of carnitine deficiency in children with chronic illness [abstracts]. Pediatr Res. 2002;51:218.
93. Stipanuk MH. Biochemical and Physiological Aspects of Human Nutrition. Philadelphia: WB Saunders Company; 2000.
94. Peluso G, Nicolai R, Reda E, et al. Cancer and anticancer therapy-induced modifications on metabolism mediated by carnitine system. J Cell Physiol. 2000;182:339-350.
95. Weatherley-Jones E, Nicholl JP, Thomas KJ, et al. A randomised, controlled, triple-blind trial of the efficacy of homeopathic treatment for chronic fatigue syndrome. J Psychosom Res. 2004;56:189-197.
96. Wild MR, Espie CA. The efficacy of hypnosis in the reduction of procedural pain and distress in pediatric oncology: a systematic review. J Dev Behav Pediatr. 2004;25:207-213.
97. Hilgard JR, LeBaron S. Relief of anxiety and pain in children and adolescents with cancer: quantitative measures and clinical observations. Int J Clin Exp Hypn. 1982;30:417-442.
98. Zeltzer L, LeBaron S. Hypnosis and nonhypnotic techniques for reduction of pain and anxiety during painful procedures in children and adolescents with cancer. J Pediatr. 1982;101:1032-1035.
99. Hawkins PJ, Liossi C, Ewart B. Hypnosis in the alleviation of procedure related pain and distress in pediatric oncology patients. Contemporary Hypnosis. 1998;15:199-207.
100. Smith JT, Barabasz A, Barabasz M. Comparison of hypnosis and distraction in severely ill children undergoing painful medical procedures. J Counsel Psychol. 1996;43:187-195.
101. Liossi C, Hatira P. Clinical hypnosis in the alleviation of procedure-related pain in pediatric oncology patients. Int J Clin Exp Hypn. 2003;51:4-28.
102. Tsao JC, Zeltzer LK. Complementary and alternative medicine approaches for pediatric pain: a review of the state-of-the-science. Evid Based Complement Alternat Med. 2005;2:149-159.
103. Deng G, Cassileth BR. Integrative oncology: complementary therapies for pain, anxiety, and mood disturbance. CA Cancer J Clin. 2005;55:109-116.
104. Cassileth B, Vickers A. Massage therapy for symptom control: outcome study at a major cancer center. J Pain Symptom Manage. 2004;28:244-249.
105. Zeltzer LK, Tsao JC, Stelling C, et al. A phase I study on the feasibility and acceptability of an acupuncture/hypnosis intervention for chronic pediatric pain. J Pain Symptom Manage. 2002;24:437-446.
106. Pintov S, Lahat E, Alstein M, et al. Acupuncture and the opioid system: implications in management of migraine. Pediatr Neurol. 1997;17:129-133.
107. Fields T, Hernandez-Reif M, Seligman S, et al. Juvenile rheumatoid arthritis: benefits from massage therapy. J Pediatr Psychol. 1997;22:607-617.
108. Hernandez-Reif M, Field T, Largie S, et al. Childrens' distress during burn treatment is reduced by massage therapy. J Burn Care Rehabil. 2001;22:191-195.
109. Redeker NS, Lev EL, Ruggiero J. Insomnia, fatigue, anxiety, depression, and quality of life of cancer patients undergoing chemotherapy. Sch Inq Nurs Pract. 2000;14:275-290.
110. Block KI, Gyllenhaal C, Mead MN. Safety and efficacy of herbal sedatives in cancer care. Integr Cancer Ther. 2004;3:128-148.
111. Schrader E. Equivalence of St John's wort extract (Ze 117) and fluoxetine: a randomized, controlled study in mild-moderate depression. Int Clin Psychopharmacol. 2000;15:61-68.
112. Gurley BJ, Gardner SF, Hubbard MA, et al. In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes. Clin Pharmacol Ther. 2005;77:415-426.
113. Connor KM, Davidson JR, Churchill LE. Adverse-effect profile of kava. CNS Spectr. 2001;6:848-853.
114. Wheatley D. Stress-induced insomnia treated with kava and valerian: singly and in combination. Hum Psychopharmacol. 2001;16:353-356.
115. Akhondzadeh S, Naghavi HR, Vazirian M, et al. Passionflower in the treatment of generalized anxiety: a pilot double-blind randomized controlled trial with oxazepam. J Clin Pharm Ther. 2001;26:363-367.
116. Francis AJ, Dempster RJ. Effect of valerian, Valeriana edulis, on sleep difficulties in children with intellectual deficits: randomised trial. Phytomedicine. 2002;9:273-279.
117. Hardy M, Kirk-Smith MD, Stretch DD. Replacement of drug treatment for insomnia by ambient odour. Lancet. 1995;346:701.
118. Lis-Balchin M, Hart S. Studies on the mode of action of the essential oil of lavender (Lavandula angustifolia P. Miller). Phytother Res. 1999;13:540-542.
119. Masago R, Matsuda T, Kikuchi Y, et al. Effects of inhalation of essential oils on EEG activity and sensory evaluation. J Physiol Anthropol Appl Human Sci. 2000;19:35-42.
120. Schulz H, Stolz C, Muller J. The effect of valerian extract on sleep polygraphy in poor sleepers: a pilot study. Pharmacopsychiatry. 1994;27:147-151.
121. Schultz V, Hubner W, Ploch M. Clinical trials with phytopsychopharmacological agents. Phytomedicine. 1997;4:379-387.
122. Buchbauer G, Jirovetz L, Jager W. Aromatherapy: evidence for sedative effects of the essential oil of Lavender after inhalation. Zeithsch Naturforschung. 1991;46:1067-1072.
123. Graham PH, Browne L, Cox H, et al. Inhalation aromatherapy during radiotherapy: results of a placebo-controlled double-blind randomized trial. J Clin Oncol. 2003;21:2372-2376.
124. Richards K, Nagel C, Markie M, et al. Use of complementary and alternative therapies to promote sleep in critically ill patients. Crit Care Nurs Clin North Am. 2003;15:329-340.
125. NIH Technology Assessment Panel on Integration of Behavioral and Relaxation Approaches into the Treatment of Chronic Pain and Insomnia. Integration of behavioral and relaxation approaches into the treatment of chronic pain and insomnia. J Am Med Assoc. 1996;276:313-318.
126. Wilkinson S, Aldridge J, Salmon I, et al. An evaluation of aromatherapy massage in palliative care. Palliat Med. 1999;13:409-417.
127. Smith MC, Kemp J, Hemphill L, et al. Outcomes of therapeutic massage for hospitalized cancer patients. J Nurs Scholarsh. 2002;34:257-262.
128. Stephenson NL, Weinrich SP, Tavakoli AS. The effects of foot reflexology on anxiety and pain in patients with breast and lung cancer. Oncol Nurs Forum. 2000;27:67-72.
129. Lawvere S. The effect of massage therapy in ovarian cancer patients. In: Rich G, ed. Massage Therapy: The Evidence for Practice. Edinburgh: Mosby; 2002:57-83.
130. Carlson LE, Ursuliak Z, Goodey E, et al. The effects of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients: 6-month follow-up. Support Care Cancer. 2001;9:112-123.
131. Cassileth BR, Vickers AJ, Magill LA. Music therapy for mood disturbance during hospitalization for autologous stem cell transplantation: a randomized controlled trial. Cancer. 2003;98:2723-2729.
132. Holland JC, Morrow GR, Schmale A, et al. A randomized clinical trial of alprazolam versus progressive muscle relaxation in cancer patients with anxiety and depressive symptoms. J Clin Oncol. 1991;9:1004-1011.
133. Petersen RW, Quinlivan JA. Preventing anxiety and depression in gynaecological cancer: a randomised controlled trial. BJOG. 2002;109:386-394.
134. Speca M, Carlson LE, Goodey E, et al. A randomized, wait-list controlled clinical trial: the effect of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in cancer outpatients. Psychosom Med. 2000;62:613-622.
135. Targ EF, Levine EG. The efficacy of a mind-body-spirit group for women with breast cancer: a randomized controlled trial. Gen Hosp Psychiatry. 2002;24:238-248.
136. Cohen AJ, Menter A, Hale L. Acupuncture: role in comprehensive cancer care - a primer for the oncologist and review of the literature. Integr Cancer Ther. 2005;4:131-143.
137. Deng G, Cassileth BR, Yeung KS. Complementary therapies for cancer-related symptoms. J Support Oncol. 2004;2:419-426.
138. Kemper KJ, Kelly EA. Treating children with therapeutic and healing touch. Pediatr Ann. 2004;33:248-252.
139. Filshie J, Rubens CN. Complementary and alternative medicine. Anesthesiol Clin North Am. 2006;24:81-111.
140. Browning DM, Solomon MZ. The initiative for pediatric palliative care: an interdisciplinary educational approach for healthcare professionals. J Pediatr Nurs. 2005;20:326-334.
141. Wolfe J, Grier HE, Klar N, et al. Symptoms and suffering at the end of life in children with cancer. N Engl J Med. 2000;342:326-333.
142. Gadsby JG, Flowerdew MW. Transcutaneous electrical nerve stimulation and acupuncture-like transcutaneous electrical nerve stimulation for chronic low back pain. Cochrane Database Syst Rev. 2000;CD000210.
143. Pan CX, Morrison RS, Ness J, et al. Complementary and alternative medicine in the management of pain, dyspnea, and nausea and vomiting near the end of life. A systematic review. J Pain Symptom Manage. 2000;20:374-387.
144. Anghelescu DL, Oakes L, Hinds PS. Palliative care and pediatrics. Anesthesiol Clin North Am. 2006;24:145-161.
145. Rushton CH. A framework for integrated pediatric palliative care: being with dying. J Pediatr Nurs. 2005;20:311-325.
146. Beider S. An ethical argument for integrated palliative care. Evid Based Complement Alternat Med. 2005;2:227-231.
147. Boon H, Westlake K, Stewart M, et al. Use of complementary/alternative medicine by men diagnosed with prostate cancer: prevalence and characteristics. Urology. 2003;62:849-853.
148. Hann D, Baker F, Denniston M, et al. Long-term breast cancer survivors' use of complementary therapies: perceived impact on recovery and prevention of recurrence. Integr Cancer Ther. 2005;4:14-20.
149. Montbriand MJ. Herbs or natural products that increase cancer growth or recurrence. Part two of a four-part series. Oncol Nurs Forum. 2004;31:E99-E115.
150. Montbriand MJ. Herbs or natural products that decrease cancer growth part one of a four-part series. Oncol Nurs Forum. 2004;31:E75-E90.
151. Montbriand MJ. Herbs or natural products that protect against cancer growth part three of a four-part series. Oncol Nurs Forum. 2004;31:E127-E146.
152. Montbriand MJ. Herbs or natural products that may cause cancer and harm part four of a four-part series. Oncol Nurs Forum. 2005;32:E20-E29.
153. Goldrosen MH, Straus SE. Complementary and alternative medicine: assessing the evidence for immunological benefits. Nat Rev Immunol. 2004;4:912-921.
154. Yang G. Immunologic effect of traditional Chinese drugs. Chin Med J (England). 1996;109:59-60.
155. Chlebowski RT. The American Cancer Society guide for nutrition and physical activity for cancer survivors: a call to action for clinical investigators. CA Cancer J Clin. 2003;53:266-267.
156. Bijlani RL, Vempati RP, Yadav RK, et al. A brief but comprehensive lifestyle education program based on yoga reduces risk factors for cardiovascular disease and diabetes mellitus. J Altern Complement Med. 2005;11:267-274.
157. Harrison LJ, Manoch R, Rubia K. Sahaja yoga meditation as a family treatment programme for children with attention deficit hyperactivity disorder. Clin Child Psychol Psych. 2004;9:479-497.
158. Linden W. Practicing of meditation by school children and their levels of field dependence-independence, test anxiety, and reading achievement. J Consult Clin Psychol. 1973;41:139-143.
159. McCloy S. A preliminary study of mindfulness in children as a conceptual framework for coping with bullying. Diss Abs Int. 2005;65:2898.
160. Murdock M. Meditation in young children. J Trans Pscyh. 1978;10:29-44.
161. Redfering D, Bowman M. Effects of meditative relaxation exercise on non-attending behaviors of behaviorally disturbed children. J Clin Child Psych. 1981;10:126-127.
162. Hayman LL, Reineke PR. Preventing coronary heart disease: the implementation of healthy lifestyle strategies for children and adolescents. J Cardiovasc Nurs. 2003;18:294-301.
163. Manjunath NK, Telles S. Spatial and verbal memory test scores following yoga and fine arts camps for school children. Indian J Physiol Pharmacol. 2004;48:353-356.
164. Naveen KV, Nagarathna R, Nagendra HR, et al. Yoga breathing through a particular nostril increases spatial memory scores without lateralized effects. Psychol Rep. 1997;81:555-561.
165. Saper RB, Eisenberg DM, Phillips RS. Common dietary supplements for weight loss. Am Fam Physician. 2004;70:1731-1738.
166. Labriola D, Livingston R. Possible interactions between dietary antioxidants and chemotherapy. Oncology (Huntington). 1999;13:1003-1008.
167. O'Mathuna DP. Evidence-based practice and reviews of therapeutic touch. J Nurs Scholarsh. 2000;32:279-285.
168. Buchanan DR, White JD, O'Mara AM, et al. Research-design issues in cancer-symptom-management trials using complementary and alternative medicine: lessons from the National Cancer Institute Community Clinical Oncology Program experience. J Clin Oncol. 2005;23:6682-6689.
169. Shen J, Wenger N, Glaspy J, et al. Electroacupuncture for control of myeloablative chemotherapy-induced emesis. A randomized controlled trial. JAMA. 2000;284:2755-2761.
170. Pearl ML, Fischer M, McCauley DL, et al. Transcutaneous electrical nerve stimulation as an adjunct for controlling chemotherapy-induced nausea and vomiting in gynecologic oncology patients. Cancer Nurs. 1999;22:307-311.
171. McMillan C, Dundee JW, Abram WP. Enhancement of the antiemetic action of ondansetron by transcutaneous electrical stimulation of the P6 antiemetic point, in patients having highly emetic cytotoxic drugs. Br J Cancer. 1991;64:971-921.
172. Vasterling J, Jenkins RA, Tope DM, et al. Cognitive distraction and relaxation training for the control of side effects due to cancer chemotherapy. J Behav Med. 1993;16:65-80.
173. Syrjala KL, Donaldson GW, Davis MW, et al. Relaxation and imagery and cognitive-behavioral training reduce pain during cancer treatment: a controlled clinical trial. Pain. 1995;63:189-198.
174. Filshie J. The non-drug treatment of neuralgic and neuropathic pain of malignancy. Cancer Surv. 1988;7:161-193.
175. Filshie J, Redman D. Acupuncture and malignant pain problems. Eur Surg Oncol. 1985;11:389-394.
176. Alimi D, Rubino C, Pichard-Leandri E, et al. Analgesic effect of auricular acupuncture for cancer pain: a randomized, blinded, controlled trial. J Clin Oncol. 2003;21:4120-4126.
177. Fowler-Kerry S, Lander JR. Management of injection pain in children. Pain. 1987;30:169-175.
178. Kline RM, Kline JJ, Di Palma J, et al. Enteric coated, pH-dependent peppermint oil capsules for the treatment of irritable bowel syndrome in children. J Pediatr. 2001;138:125-128.
179. Weydert JA, Ball TM, Davis MF. Systematic review of treatments for recurrent abdominal pain. Pediatrics. 2003;111:e1-e11.
180. Kellerman J, Zeltzer L, Ellenberg L, et al. Hynposis for the reduction of the acute pain and anxiety associated with medical procedures. J Adolesc Health Care. 1983;4:85-90.
181. Katz ER, Kellerman J, Ellenberg L. Hypnosis in the reduction of acute pain and distress in children with cancer. J Pediatr Psychol. 1987;12:379-394.
182. Kuttner L, Bowman M, Teasdale M. Psychological treatment of distress, pain, and anxiety for young children with cancer. J Dev Behav Pediatr. 1988;9:374-381.
183. Wall VJ, Womack W. Hypnotic versus active cognitive strategies for alleviation of procedural distress in pediatric oncology patients. Am J Clin Hypn. 1989;31:181-192.
184. Spiegel D, Bloom JR. Group therapy and hypnosis reduce metastatic breast carcinoma pain. Psychosom Med. 1983;45:333-339.
185. Syrjala KL, Cummings C, Donaldson GW. Hypnosis or cognitive behavioral training for the reduction of pain and nausea during cancer treatment: a controlled clinical trial. Pain. 1992;48:137-146.
186. Syrjala KL, Donaldson GW, Davis MW, et al. Relaxation and imagery and cognitive-behavioral training reduce pain during cancer treatment: a controlled clinical trial. Pain. 1995;63:189-198.
187. Liossi C, Hatira P. Clinical hypnosis versus cognitive behavioral training for pain management with pediatric cancer patients undergoing bone marrow aspirations. Int J Clin Exp Hypn. 1999;47:104-116.
188. Decker TW, Clineelsen J, Gallagher M. Relaxation therapy as an adjunct in radiation oncology. J Clin Psychol. 1992;48:388-393.
189. Leathwood PD, Chauffard F, Heck E, et al. Aqueous extract of valerian root (Valeriana officinalis L) improves sleep quality in man. Pharmacol Biochem Behav. 1982;17:65-71.
190. Lindall O, Lindwall L. Double blind study of a valerian preparation. Pharmacol Biochem Behav. 1989;32:1065-1066.
191. Herrera-Arellano A, Luna-Villegas G, Cuevas-Uriostegui M, et al. Polysomnographic evaluation of the hypnotic effect of Valeriana edulis
192. Donath F, Quispe S, Diefenbach K, et al. Critical evaluation of the effect of valerian extract on sleep structure and sleep quality. Pharmacopsychiatry. 2000;33:47-53.
193. Poyares DR, Guilleminault C, Ohayon MM, et al. Can valerian improve the sleep of insomniacs after benzodiazepine withdrawal? Prog Neuropsychopharmacol Biol Psychiatry. 2002;26:539-545.
194. Schmitz M, Jackel M. Comparative study for assessing quality of life of patients with exogenous sleep disorders (temporary sleep onset and sleep interruption disorders) treated with a hops-valerian preparation and a benzodiazepine drug [abstract]. Wien Med Wochenschr. 1998;148:291-298.
195. Dominguez RA, BravopValverde RL, Kaplowitz BR, et al. Valerian as a hypnotic for Hispanic patients. Cultur Divers Ethnic Minor Psychol. 2000;6:84-92.
196. Dorn M. Efficacy and tolerability of Baldrian versus oxazepam innon-organic and non-psychiatric insomniacs: a randomized, double-blind, clinical, comparative study [abstract]. Forsch Komplementarmed Klass Naturheilkd. 2000;7:79-84.
197. Ziegler G, Ploch M, Miettinen-Baumann A, et al. Efficacy and tolerability of valerian extract L1 156 compared with oxazepam in the treatment of non-organic insomnia - a randomized, double-blind comparative clinical study. Eur J Med Res. 2002;7:480-486.
198. Balderer G, Borbely AA. Effect of valerian on human sleep. Psychopharmacology. 1985;87:273-279.
199. Glass JR, Sproule BA, Herrmann N, et al. Acute pharmacological effects of temazepam, diphenhydramine, and valerian in healthy elderly subjects. J Clin Psychopharmacol. 2003;23:260-268.
200. Pittler MH, Ernst E. Kava extract for treating anxiety. Cochrane Database Syst Rev. 2003;CD003383.
201. Lehmann E, Kinzler E, Friedemann J. Efficacy of a special kava extract (Piper methysticum) in patients with states of anxiety, tension and excitedness of non-mental origin: a double-blind placebo-controlled study of four weeks treatment. Phytomedicine. 1996;3:113-119.
202. Volz HP, Kieser M. Kava-kava extract WS 1490 versus placebo in anxiety disorders: a randomized placebo-controlled 25-week outpatient trial. Pharmacopsychiatry. 1997;30:1-5.
203. Emser W, Bartylla K. Improvement of sleep quality. Neurologie/ Psychiatrie. 1991;5:636-642.
204. Gould L, Reddy CV, Gomprecht RF. Cardiac effects of chamomile tea. J Clin Pharmacol. 1973;13:475-479.
205. Louis M, Kowalski SD. Use of aromatherapy with hospice patients to decreas pain, anxiety, and depression and to promote an increased sense of well-being. Am J Hosp Palliat Care. 2002;19:381-386.
206. Blumenthal M. The Commission E. Monographs. Austin, TX: American Botanical Council; 1998.
207. Moyer CA, Rounds J, Hannum JW. A meta-analysis of massage therapy research. Psychol Bul. 2004;130:3-18.
208. Wall VJ, Womack W. Hypnotic versus active cognitive strategies for alleviation of procedural distress in pediatric oncology patients. Am J Clin Hypn. 1989;31:181-192.
209. Kellerman J, Zeltzer L, Ellenberg L, et al. Hypnosis for the reduction of the acute pain and anxiety associated with medical procedures. J Adolesc Health Care. 1983;4:85-90.
210. Smith JT, Barabasz A, Barabasz M. Comparison of hypnosis and distraction in severely ill children undergoing painful medical procedures. J Couns Psychol. 1996;43:187-195.
211. Decker TW, Clineelsen J, Gallagher M. Relaxation therapy as an adjunct in radiation oncology. J Clin Psychol. 1992;48:388-393.
212. Grealish L, Lomasney A, Whiteman B. Foot massage: a nursing intervention to modify the distressing symptoms of pain and nausea in patients hospitalized with cancer. Cancer Nurs. 2000;23:237-243.
213. Berrera ME, Rykov MH, Doyle SL. The effects of interactive music therapy on hospitalize children with cancer: a pilot study. Psychooncology. 2002;11:379-388.
214. Aquino VM, Harvey AR, Garvin JH, et al. A double-blind randomized placebo-controlled study of oral glutamine in the prevention of mucositis in children undergoing hematopoietic stem cell transplantation: a pediatric blood and marrow transplant consortium study. Bone Marrow Transplant. 2005;36:611-616.
215. Malone AB. The effects of live music on the distress of pediatric patients receiving intravenous starts, venipunctures, injections, and heel sticks. J Music Ther. 1996;33:19-33.
216. Sloman R. Relaxation and the relief of cancer pain. Nursing Clin North Am. 2005;30:697-709.